Albireo Pharma Incの時価総額
Albireo Pharma Incの時価総額は何ですか。
Albireo Pharma Incの時価総額は492.28M$です。
時価総額の定義は何ですか。
時価総額は、取引された会社の発行済株式の市場価値であり、一定期間のb株式に発行済株式数を掛けたものに等しい。
As outstanding stock is bought and sold in public markets, capitalization could be used as an indicator of public opinion of a company's net worth and is a determining factor in some forms of stock valuation.
Market capitalization is used by the investment community in ranking the size of companies, as opposed to sales or total asset figures. It is also used in ranking the relative size of stock exchanges, being a measure of the sum of the market capitalizations of all companies listed on each stock exchange. In performing such rankings, the market capitalizations are calculated at some significant date, such as 30 June or 31 December.
The total capitalization of stock markets or economic regions may be compared with other economic indicators. The total market capitalization of all publicly traded companies in the world was US$51.2 trillion in January 2007 and rose as high as US$57.5 trillion in May 2008 before dropping below US$50 trillion in August 2008 and slightly above US$40 trillion in September 2008. In 2014 and 2015, global market capitalization was US$68 trillion and US$67 trillion, respectively.
NASDAQのセクタHealth Careにおける時価総額の企業と比べるAlbireo Pharma Inc
Albireo Pharma Incは何をしますか。
Albireo Pharma is a clinical-stage biopharmaceutical company focused on the development of novel bile acid modulators to treat rare pediatric and adult liver diseases, and other adult liver diseases and disorders. Albireo's lead product candidate, odevixibat, is being developed to treat rare pediatric cholestatic liver diseases with Phase 3 pivotal trials in PFIC, Alagille syndrome and biliary atresia. The Company completed IND-enabling studies for new preclinical candidate A3907 this year and plans to advance development in adult liver disease. Albireo was spun out from AstraZeneca in 2008 and is headquartered in Boston, Massachusetts, with its key operating subsidiary in Gothenburg, Sweden. The Boston Business Journal named Albireo one of the 2020 Best Places to Work in Massachusetts for the second consecutive year.
Albireo Pharma Incと類似の時価総額
- NOCILの時価総額は491.44M$です。
- Nektar Therapeuticsの時価総額は491.50M$です。
- Tejon Ranch Coの時価総額は491.61M$です。
- Sisram Medical Ltdの時価総額は491.70M$です。
- enCoreの時価総額は491.81M$です。
- Garrett Motion Incの時価総額は491.97M$です。
- Albireo Pharma Incの時価総額は492.28M$です。
- Brasilagro Companhia Brasileira De Propriedade Agricolaの時価総額は492.33M$です。
- Premier Gold Minesの時価総額は493.21M$です。
- Beijing Enterprises Cleanの時価総額は493.64M$です。
- Xinyuan Ppty Mgmt Svcの時価総額は493.73M$です。
- IQE Plcの時価総額は494.04M$です。
- South Plains Incの時価総額は494.72M$です。